Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence (AI)-powered software platforms.

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.

The chemical-and-materials maker on Tuesday forecast sales around $12.85 billion and adjusted earnings per share around $4.40. The Wilmington, Del., company previously guided for sales between $12.8 ...

Palantir reported better-than-expected quarterly results, but restaurant chain Denny's and Hims & Hers Health posted disappointing results.

These 10 stocks could mint the next wave of millionaires › SBA Communications (NASDAQ:SBAC), a leading owner and operator of wireless communications towers, announced results for the second quarter on ...

EMCOR Group delivered above-expectations results in Q2 2025 with the management raising its full-year guidance. Read more on ...

2025 full-year revenue guidance -- Revenue is now expected to be between $1.645 billion and $1.655 billion for 2025. 2025 ...

Bristol Myers Squibb offers a 5.6% dividend yield, strong cash flow, and AI-driven growth potential. See why I see this as a ...

Average interest-earning assets for fiscal Q2 2025 were $13.6 billion. Non-Interest Income: Non-interest income for fiscal Q2 ...